The BMJ: curcumin may be used to help treat cancer

Recently, the British Medical Journal reported a strange case of cancer rehabilitation A woman with advanced myeloma tried curcumin every day after various treatments failed Five years later, the cancer was under control and her indicators returned to the normal level In 2007, Rene Ferguson, 67, was diagnosed with a myeloma and deteriorated to phase III within 15 months After three failed chemotherapy and four failed stem cell transplants, doctors told her there was little hope "I've been taking a variety of drugs, including serious side effects," she said Once, she lost three days of memory Another time, two vertebrae of her spine collapsed and had to be strengthened to maintain stability Four years after her initial diagnosis, she began to take curcumin, a key ingredient in curcumin, on her own every day She takes about 8 grams on an empty stomach every night Since then, her cancer has stabilized, her blood has returned to normal and her quality of life has improved When she told the oncologist that she had been taking curcumin, the doctor was interested in the difference Myeloma is the second most common form of blood cancer, starting with plasma cells in the bone marrow When these cells start to mutate and proliferate, they will gradually become myeloma, causing severe pain, nerve damage, fatigue and bone damage Treatment usually can only control the symptoms and can't be cured People usually don't live for five years Ferguson's results show that ginger can be used to help patients with myeloma in the future "In fact, our patients are in the advanced stage of cancer, and curcumin saves lives, which shows the potential anti-tumor effect of curcumin," he added Co authors of the report said there was no possible explanation other than curcumin Scientists suggest further evaluation in clinical trials to explore the possibility of using it as an official treatment However, it can be very difficult for doctors to prescribe the drug unless millions of dollars are spent on large-scale experimental tests This natural compound cannot be patented and it is very difficult to find an investor.